Harold H. Wolf

3.4k total citations
62 papers, 2.8k citations indexed

About

Harold H. Wolf is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Harold H. Wolf has authored 62 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 20 papers in Psychiatry and Mental health. Recurrent topics in Harold H. Wolf's work include Neuroscience and Neuropharmacology Research (31 papers), Epilepsy research and treatment (20 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Harold H. Wolf is often cited by papers focused on Neuroscience and Neuropharmacology Research (31 papers), Epilepsy research and treatment (20 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Harold H. Wolf collaborates with scholars based in United States, Italy and Switzerland. Harold H. Wolf's co-authors include H. Steve White, José H. Woodhead, Brian D. Klein, Matthew E. Barton, S. D. Brown, Ewart A. Swinyard, H. J. Kupferberg, R. Duane Sofia, Michael Johnson and Nancy C. Lan and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Harold H. Wolf

62 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold H. Wolf United States 21 1.7k 1.1k 1.0k 574 272 62 2.8k
Markus Schmutz Switzerland 26 1.8k 1.1× 745 0.7× 1.1k 1.0× 430 0.7× 236 0.9× 53 2.7k
Ewart A. Swinyard United States 23 1.7k 1.0× 1.2k 1.1× 1.1k 1.0× 677 1.2× 742 2.7× 80 3.2k
Dagmar Hönack Germany 30 2.3k 1.3× 1.5k 1.4× 1.0k 1.0× 954 1.7× 98 0.4× 48 3.1k
Wolfgang Löscher Germany 23 1.4k 0.8× 937 0.8× 563 0.5× 566 1.0× 91 0.3× 32 2.3k
Michael E. Newman Israel 31 1.3k 0.8× 670 0.6× 853 0.8× 151 0.3× 219 0.8× 132 3.0k
W Gommeren Belgium 30 2.3k 1.3× 1000 0.9× 1.9k 1.8× 126 0.2× 193 0.7× 55 4.2k
L. Turski Poland 29 2.4k 1.4× 963 0.8× 1.0k 1.0× 441 0.8× 84 0.3× 57 3.1k
Sean D. Donevan United States 30 1.7k 1.0× 594 0.5× 1.5k 1.4× 263 0.5× 105 0.4× 50 2.9k
R J Baldessarini United States 28 946 0.5× 566 0.5× 746 0.7× 119 0.2× 117 0.4× 62 2.1k
Moshe Rehavi Israel 34 1.6k 0.9× 598 0.5× 1.3k 1.2× 176 0.3× 133 0.5× 123 3.8k

Countries citing papers authored by Harold H. Wolf

Since Specialization
Citations

This map shows the geographic impact of Harold H. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold H. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold H. Wolf more than expected).

Fields of papers citing papers by Harold H. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold H. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold H. Wolf. The network helps show where Harold H. Wolf may publish in the future.

Co-authorship network of co-authors of Harold H. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Harold H. Wolf. A scholar is included among the top collaborators of Harold H. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold H. Wolf. Harold H. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jordan, Karin, et al.. (2009). 3087 The NK-1 antagonist aprepitant (APR) in combination with granisetron and dexamethasone in high dose chemotherapy (HDC). European Journal of Cancer Supplements. 7(2). 200–201. 1 indexed citations
2.
Barton, Matthew E., Brian D. Klein, Harold H. Wolf, & H. Steve White. (2001). Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Research. 47(3). 217–227. 474 indexed citations
3.
Fariello, Ruggero G., Robert A. McArthur, A. Bonsignori, et al.. (1998). Preclinical Evaluation of PNU-151774E as a Novel Anticonvulsant. Journal of Pharmacology and Experimental Therapeutics. 285(2). 397–403. 64 indexed citations
4.
Rostock, A, C. Tober, Reni Bartsch, et al.. (1997). AWD 140–190: a new anticonvulsant with a very good margin of safety. Epilepsy Research. 28(1). 17–28. 9 indexed citations
5.
White, H. Steve, et al.. (1995). Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Research. 20(1). 41–48. 57 indexed citations
6.
White, H. Steve, et al.. (1993). Anticonvulsant activity of the γ-aminobutyric acid uptake inhibitor N-4,4-diphenyl-3-butenyl-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol. European Journal of Pharmacology. 236(1). 147–149. 15 indexed citations
7.
Swinyard, Ewart A., et al.. (1987). Hypnotic action of pentobarbital in mice: A possible mechanism. Experimental Neurology. 97(1). 70–76. 14 indexed citations
8.
Swinyard, Ewart A., et al.. (1984). Benzodiazepine inhibition of flunitrazepam receptor binding, adenosine uptake, and pentylenetetrazol-induced seizures in mice. Canadian Journal of Physiology and Pharmacology. 62(1). 132–135. 11 indexed citations
9.
10.
Swinyard, Ewart A., et al.. (1983). Pentylenetetrazol May Discriminate Between Different Types of Benzodiazepine Receptors. Journal of Neurochemistry. 41(3). 830–833. 29 indexed citations
11.
Miya, Tom S., et al.. (1980). Faculty Scholarship and Research: Their Importance to the Future of Pharmacy Education. The 1980 AACP Argus Commission Report. American Journal of Pharmaceutical Education. 44(4). 393–404. 6 indexed citations
12.
Wolf, Harold H., et al.. (1975). Morphine's proconvulsant action: Importance of endogenous norepinephrine. Life Sciences. 16(11). 1659–1668. 4 indexed citations
13.
Witiak, Donald T., Shiv K. Seth, Eugene R. Baizman, Stuart Weibel, & Harold H. Wolf. (1972). p-Substituted N-acetyl-L-(S)- and D(R)-.alpha.-amino-N-phenylsuccinimides and -glutarimides. Substituent effects on stereoselective anticonvulsant activity. Journal of Medicinal Chemistry. 15(11). 1117–1123. 12 indexed citations
14.
Wolf, Harold H., et al.. (1970). Laboratory Evaluation of Aggressive Behavior of the Grasshopper Mouse (Onychomys). Journal of Pharmaceutical Sciences. 59(7). 969–971. 27 indexed citations
15.
Wolf, Harold H., et al.. (1968). Effects of Some Adrenergic Agents on Low Frequency Electroshock Seizures. Journal of Pharmaceutical Sciences. 57(2). 340–342. 20 indexed citations
16.
Rudy, Thomas A. & Harold H. Wolf. (1967). RELATION OF CHLORPROMAZINE-EVOKED HYPOTHERMIA TO DISRUPTION OF CONDITIONED AVOIDANCE-ESCAPE BEHAVIOR. Journal of Pharmacology and Experimental Therapeutics. 156(2). 397–406. 2 indexed citations
17.
Wolf, Harold H.. (1966). Chemical Pharmacology. American Journal of Pharmaceutical Education. 30(5). 754–758. 7 indexed citations
18.
Wolf, Harold H., et al.. (1964). Drug-Induced Hyperthermia and Amphetamine Toxicity. Journal of Pharmaceutical Sciences. 53(7). 748–752. 12 indexed citations
19.
Wolf, Harold H., Ewart A. Swinyard, & Laurie Goodman. (1962). Anticonvulsant Properties of Some N-Substituted Hydantoins. Journal of Pharmaceutical Sciences. 51(1). 74–76. 10 indexed citations
20.
Swinyard, Ewart A., Lincoln D. Clark, J. T. Miyahara, & Harold H. Wolf. (1961). STUDIES ON THE MECHANISM OF AMPHETAMINE TOXICITY IN AGGREGATED MICE. Journal of Pharmacology and Experimental Therapeutics. 132(1). 97–102. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Schmutz Breakdown of academic impact, for papers by Ewart A. Swinyard Breakdown of academic impact, for papers by Dagmar Hönack Breakdown of academic impact, for papers by Wolfgang Löscher Breakdown of academic impact, for papers by Michael E. Newman Breakdown of academic impact, for papers by W Gommeren Breakdown of academic impact, for papers by L. Turski Breakdown of academic impact, for papers by Sean D. Donevan Breakdown of academic impact, for papers by R J Baldessarini Breakdown of academic impact, for papers by Moshe Rehavi
Rankless by CCL
2026